{'fraction_non_alphanumeric': 0.03329065300896287, 'fraction_numerical': 0.03329065300896287, 'mean_word_length': 5.109375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Changes in blood iron levels during cisplatin chemotherapy. Preliminary results].

Iron levels during cisplatin chemotherapy were evaluated in 23 neoplastic patients who received a total of 59 courses of cisplatin 80-100 mg/m2. In all cases hypersideraemia developed within 24 hours: iron mean value increased from 70.5 micrograms/dl to 237.4 micrograms/dl (p less than 0.001). Return to basal levels was achieved after 8-9 days. Indirect bilirubin, lactic-dehydrogenase, haemoglobin and red cells levels remained unmodified; reticulocyte count decreased only after 4 days, so making unlikely that a drug-induced haemolysis or a reduced iron utilization by inhibitory effect of cisplatin on erithron could be the cause of hypersideraemia, which at this moment remains unexplained.